Avançar para navegação principal Avançar para pesquisar Avançar para conteúdo principal

Evening and morning peroxiredoxin-2 redox/oligomeric state changes in obstructive sleep apnea red blood cells: Correlation with polysomnographic and metabolic parameters

  • Amélia Feliciano
  • , Fátima Vaz
  • , Vukosava M. Torres
  • , Cristina Valentim-Coelho
  • , Rita Silva
  • , Vesna Prosinecki
  • , Bruno M. Alexandre
  • , Ana S. Carvalho
  • , Rune Matthiesen
  • , Atul Malhotra
  • , Paula Pinto
  • , Cristina Bárbara
  • , Deborah Penque*
  • *Autor correspondente para este trabalho

Resultado de pesquisarevisão de pares

14 Citações (Scopus)

Resumo

We have examined the effects of Obstructive Sleep Apnea (OSA) on red blood cell (RBC) proteome variation at evening/morning day time to uncover new insights into OSA-induced RBC dysfunction that may lead to OSA manifestations. Dysregulated proteins mainly fall in the group of catalytic enzymes, stress response and redox regulators such as peroxiredoxin 2 (PRDX2). Validation assays confirmed that at morning the monomeric/dimeric forms of PRDX2 were more overoxidized in OSA RBC compared to evening samples. Six month of positive airway pressure (PAP) treatment decreased this overoxidation and generated multimeric overoxidized forms associated with chaperone/transduction signaling activity of PRDX2. Morning levels of overoxidized PRDX2 correlated with polysomnographic (PSG)-arousal index and metabolic parameters whereas the evening level of disulfide-linked dimer (associated with peroxidase activity of PRDX2) correlated with PSG parameters. After treatment, morning overoxidized multimer of PRDX2 negatively correlated with fasting glucose and dopamine levels. Overall, these data point toward severe oxidative stress and altered antioxidant homeostasis in OSA RBC occurring mainly at morning time but with consequences till evening. The beneficial effect of PAP involves modulation of the redox/oligomeric state of PRDX2, whose mechanism and associated chaperone/transduction signaling functions deserves further investigation. RBC PRDX2 is a promising candidate biomarker for OSA severity and treatment monitoring, warranting further investigation and validation.

Idioma originalEnglish
Páginas (de-até)621-629
Número de páginas9
RevistaBiochimica et Biophysica Acta - Molecular Basis of Disease
Volume1863
Número de emissão2
DOIs
Estado da publicaçãoPublicado - 1 fev. 2017
Publicado externamenteSim

Impressão digital

Mergulhe nos tópicos de investigação de “Evening and morning peroxiredoxin-2 redox/oligomeric state changes in obstructive sleep apnea red blood cells: Correlation with polysomnographic and metabolic parameters“. Em conjunto formam uma impressão digital única.

Citação